股本结构

单位:万股
公告日期 2023-09-29 2023-08-08 2023-08-08 2023-05-09 2023-04-28 2023-05-09
证券总股本 2705.08 2705.45 2705.84 2685.13 2686.50 2686.85
普通股本 2705.08 2705.45 2705.84 2685.13 2686.50 2686.85
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2023-09-28 2023-07-28 2023-06-30 2023-04-30 2023-04-17 2023-03-31
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2023-09-29 2705.08 未披露 定期报告 2023-09-28
2023-08-08 2705.45 未披露 定期报告 2023-07-28
2023-08-08 2705.84 未披露
更多>>
From March 31, 2023 to June 30, 2023 Exercise of stock options, net of shares withheld Issuance of restricted stock
2023-06-30
2023-05-09 2685.13 未披露 定期报告 2023-04-30
2023-04-28 2686.50 未披露 定期报告 2023-04-17
2023-05-09 2686.85 未披露
更多>>
From January 1, 2023 to March 31, 2023 Exercise of stock options, net of shares withheld Issuance of restricted stock
2023-03-31
2023-03-10 2687.07 未披露 定期报告 2023-02-28
2023-03-10 2712.91 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of restricted stock Exercise of stock options, net of shares withheld Issuance of common stock awards Vesting of restricted stock units Shares withheld for payment of employee taxes
2022-12-31
2022-11-04 2712.43 未披露 定期报告 2022-10-15
2022-11-04 2708.14 未披露
更多>>
From June 30, 2022 to September 30, 2022 Shares withheld for payment of employee taxes Forfeitures of restricted shares Issuance of restricted stock Exercise of stock options, net of shares withheld Issuance of common stock awards
2022-09-30
2022-08-05 2625.10 未披露 定期报告 2022-07-29
2022-08-05 2626.02 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld Forfeitures of restricted shares
2022-06-30
2022-05-09 2584.93 未披露 定期报告 2022-04-30
2022-04-28 2585.19 未披露 定期报告 2022-04-18
2022-05-09 2585.31 未披露
更多>>
From January 1, 2022 to March 31, 2022 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld
2022-03-31
2022-02-25 2573.18 未披露 定期报告 2022-02-16
2022-02-25 2566.64 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld
2021-12-31
2021-11-05 2571.87 未披露 定期报告 2021-10-31
2021-11-05 2503.23 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of restricted stock Exercise of stock options, net of shares withheld
2021-09-30
2021-08-06 2502.29 未披露 定期报告 2021-07-26
2021-08-06 2502.29 未披露
更多>>
from March 31, 2021 to June 30, 2021 Issuance of restricted stock Exercise of stock options, net of shares withheld Forfeitures of restricted shares
2021-06-30
2021-05-07 2484.33 未披露 定期报告 2021-04-23
2021-04-29 2484.30 未披露 定期报告 2021-04-19
2021-05-07 2507.77 未披露
更多>>
From January 1, 2021 to March 31, 2021 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld Forfeitures of restricted shares
2021-03-31
2021-02-26 2468.25 未披露 定期报告 2021-02-16
2021-02-26 2400.49 未披露
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common stock in connection with acquisition Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld Issuance of common stock in connection with the settlement of acquisition-related contingent consideration Forfeitures of restricted shares Share adjustment
2020-12-31
2020-11-06 2382.80 未披露 定期报告 2020-10-23
2020-11-06 2326.46 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of restricted stock Exercise of stock options,net of shares withheld Issuance of common stock in connection with the settlement of acquisition-related contingent consideration Forfeitures of restricted shares
2020-09-30
2020-08-06 2296.04 未披露 定期报告 2020-07-24
2020-08-06 2295.53 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of restricted stock Forfeitures of restricted shares Exercise of stock options
2020-06-30
2020-05-08 2302.09 未披露 定期报告 2020-04-21
2020-05-08 2281.75 未披露
更多>>
From January 1, 2020 to March 31, 2020 Issuance of common stock awards Issuance of restricted stock Exercise of stock options Forfeitures of restricted shares Share adjustment
2020-03-31
2020-03-02 2238.16 未披露 定期报告 2020-02-15
2020-03-02 2232.13 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of common stock in connection with acquisition Issuance of common stock awards Issuance of restricted stock Exercise of stock options Issuance of common stock in connection with the settlement of acquisition-related contingent consideration Exercise of stock options
2019-12-31
2019-11-08 2220.50 未披露 定期报告 2019-10-31
2019-11-08 2219.21 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common stock awards Exercise of stock options
2019-09-30
2019-08-09 2208.82 未披露 定期报告 2019-07-31
2019-08-09 2208.18 未披露
更多>>
From March 31, 2019 to June 30, 2019 Issuance of common stock awards Issuance of restricted stock Exercise of stock options
2019-06-30
2019-05-10 2198.83 未披露 定期报告 2019-04-30
2019-04-30 2198.50 未披露 定期报告 2019-04-23
2019-05-10 2197.82 未披露
更多>>
from January 1, 2019 to March 31, 2019 Issuance of common stock in connection with acquisition Issuance of common stock awards Issuance of restricted stock Exercise of stock options Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
2019-03-31
2019-03-01 2112.86 未披露 定期报告 2019-02-25
2019-03-01 2055.75 未披露
更多>>
from December 31, 2017 to December 31, 2018 Forfeitures of restricted shares Shares repurchased Net exercise of stock options Exercise of stock options
2018-12-31
2018-11-08 2046.59 未披露 定期报告 2018-10-31
2018-11-08 2035.66 未披露
更多>>
from January 1, 2018 to September 30, 2018 Issuance of common stock in connection with acquisition Issuance of restricted stock Net exercise of stock options Exercise of stock options
2018-09-30
2018-08-08 2024.29 未披露 定期报告 2018-07-31
2018-08-08 2022.56 未披露
更多>>
from January 1, 2018 to June 30, 2018 Issuance of restricted stock Net exercise of stock options Exercise of stock options Shares surrendered by stockholder Shares repurchased
2018-06-30
2018-05-09 2000.61 未披露 定期报告 2018-04-30
2018-05-01 2000.54 未披露 定期报告 2018-04-24
2018-05-09 2014.12 未披露
更多>>
from January 1, 2018 to March 31, 2018 Issuance of restricted stock Net exercise of stock options Exercise of stock options Shares surrendered by stockholder Shares repurchased
2018-03-31
2018-03-14 2001.35 未披露 定期报告 2018-02-28
2018-03-14 1929.75 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Issuance of common stock in connection with acquisition Issuance of restricted stock Shares surrendered by stockholder Net exercise of stock warrants Net exercise of stock options Exercise of stock options
2017-12-31
2017-11-09 1784.90 未披露 定期报告 2017-10-31
2017-11-09 1783.19 未披露
更多>>
From January 1, 2017 to September 30, 2017 Issuance of common stock in connection with acquisition Issuance of restricted stock Shares surrendered by stockholder Shares repurchased Net exercise of stock warrants Net exercise of stock options Exercise of stock options
2017-09-30
2017-08-08 1736.02 未披露 定期报告 2017-07-31
2017-08-08 1728.68 未披露
更多>>
From January 1, 2017 to June 30, 2017 Issuance of restricted stock Shares surrendered by stockholder Net exercise of stock warrants Net exercise of stock options Exercise of stock options Shares repurchased
2017-06-30
2017-05-02 1721.82 未披露 定期报告 2017-04-15
2017-05-02 1709.71 未披露
更多>>
from January 1, 2017 to March 31, 2017 Issuance of restricted stock Shares surrendered by stockholder Net exercise of stock options Exercise of stock options
2017-03-31
2017-03-14 1707.31 未披露 定期报告 2017-02-28
2017-03-14 1662.85 未披露
更多>>
from December 31, 2015 to December 31, 2016 Conversion of redeemable convertible preferred stock upon initial public offering Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy Transfer of common stock Issuance of common stock Issuance of restricted stock Redesignation of Class A and Class B common stock upon initial public offering Net exercise of stock warrants Net exercise of stock options Issuance of common stock upon initial public offering, net of issuance costs Surrender of common stock Issuance of common stock in connection with Leadership Exit Bonus Plan Shares withheld for tax in connection with Leadership Exit Bonus Plan Issuance of common stock in connection with satisfaction of acquisition consideration related to asset acquisition of 9176-1916 Quebec, Inc. Exercise of stock options The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016.
2016-12-31
2016-11-10 1610.12 未披露 定期报告 2016-10-31
2016-11-10 558.34 987.35
更多>>
From January 1, 2016 to September 30, 2016 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy Transfer of common stock Issuance of common stock Net exercise of stock warrants Net exercise of stock options Issuance of restricted stock
2016-09-30
2016-09-29 1558.46 未披露
更多>>
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
2016-09-29
2016-09-19 486.08 987.35
更多>>
From January 1, 2016 to June 30, 2016 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy Transfer of common stock Issuance of common stock Net exercise of stock warrants Net exercise of stock options The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
2016-06-30
2016-07-21 943.00 987.35
更多>>
From January 1,2016 to March 31, 2016 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy Transfer of common stock Net exercise of stock warrants Net exercise of stock options
2016-03-31
2016-01-04 887.12 987.35
更多>>
from January 1, 2015 to September 30, 2015 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of Capstone Performance Systems, LLC Transfer of common stock Exercise of stock options
2015-09-30
From March 31, 2023 to June 30, 2023 Exercise of stock options, net of shares withheld Issuance of restricted stock
From January 1, 2023 to March 31, 2023 Exercise of stock options, net of shares withheld Issuance of restricted stock
From December 31, 2021 to December 31, 2022 Issuance of restricted stock Exercise of stock options, net of shares withheld Issuance of common stock awards Vesting of restricted stock units Shares withheld for payment of employee taxes
From June 30, 2022 to September 30, 2022 Shares withheld for payment of employee taxes Forfeitures of restricted shares Issuance of restricted stock Exercise of stock options, net of shares withheld Issuance of common stock awards
From March 31, 2022 to June 30, 2022 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld Forfeitures of restricted shares
From January 1, 2022 to March 31, 2022 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld
From December 31, 2020 to December 31, 2021 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld
From June 30, 2021 to September 30, 2021 Issuance of restricted stock Exercise of stock options, net of shares withheld
from March 31, 2021 to June 30, 2021 Issuance of restricted stock Exercise of stock options, net of shares withheld Forfeitures of restricted shares
From January 1, 2021 to March 31, 2021 Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld Forfeitures of restricted shares
From December 31, 2019 to December 31, 2020 Issuance of common stock in connection with acquisition Issuance of common stock awards Issuance of restricted stock Exercise of stock options, net of shares withheld Issuance of common stock in connection with the settlement of acquisition-related contingent consideration Forfeitures of restricted shares Share adjustment
From June 30, 2020 to September 30, 2020 Issuance of restricted stock Exercise of stock options,net of shares withheld Issuance of common stock in connection with the settlement of acquisition-related contingent consideration Forfeitures of restricted shares
From March 31, 2020 to June 30, 2020 Issuance of restricted stock Forfeitures of restricted shares Exercise of stock options
From January 1, 2020 to March 31, 2020 Issuance of common stock awards Issuance of restricted stock Exercise of stock options Forfeitures of restricted shares Share adjustment
from December 31, 2018 to December 31, 2019 Issuance of common stock in connection with acquisition Issuance of common stock awards Issuance of restricted stock Exercise of stock options Issuance of common stock in connection with the settlement of acquisition-related contingent consideration Exercise of stock options
from June 30, 2019 to September 30, 2019 Issuance of common stock awards Exercise of stock options
From March 31, 2019 to June 30, 2019 Issuance of common stock awards Issuance of restricted stock Exercise of stock options
from January 1, 2019 to March 31, 2019 Issuance of common stock in connection with acquisition Issuance of common stock awards Issuance of restricted stock Exercise of stock options Issuance of common stock in connection with the settlement of acquisition-related contingent consideration
from December 31, 2017 to December 31, 2018 Forfeitures of restricted shares Shares repurchased Net exercise of stock options Exercise of stock options
from January 1, 2018 to September 30, 2018 Issuance of common stock in connection with acquisition Issuance of restricted stock Net exercise of stock options Exercise of stock options
from January 1, 2018 to June 30, 2018 Issuance of restricted stock Net exercise of stock options Exercise of stock options Shares surrendered by stockholder Shares repurchased
from January 1, 2018 to March 31, 2018 Issuance of restricted stock Net exercise of stock options Exercise of stock options Shares surrendered by stockholder Shares repurchased
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Issuance of common stock in connection with acquisition Issuance of restricted stock Shares surrendered by stockholder Net exercise of stock warrants Net exercise of stock options Exercise of stock options
From January 1, 2017 to September 30, 2017 Issuance of common stock in connection with acquisition Issuance of restricted stock Shares surrendered by stockholder Shares repurchased Net exercise of stock warrants Net exercise of stock options Exercise of stock options
From January 1, 2017 to June 30, 2017 Issuance of restricted stock Shares surrendered by stockholder Net exercise of stock warrants Net exercise of stock options Exercise of stock options Shares repurchased
from January 1, 2017 to March 31, 2017 Issuance of restricted stock Shares surrendered by stockholder Net exercise of stock options Exercise of stock options
from December 31, 2015 to December 31, 2016 Conversion of redeemable convertible preferred stock upon initial public offering Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy Transfer of common stock Issuance of common stock Issuance of restricted stock Redesignation of Class A and Class B common stock upon initial public offering Net exercise of stock warrants Net exercise of stock options Issuance of common stock upon initial public offering, net of issuance costs Surrender of common stock Issuance of common stock in connection with Leadership Exit Bonus Plan Shares withheld for tax in connection with Leadership Exit Bonus Plan Issuance of common stock in connection with satisfaction of acquisition consideration related to asset acquisition of 9176-1916 Quebec, Inc. Exercise of stock options The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016.
From January 1, 2016 to September 30, 2016 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy Transfer of common stock Issuance of common stock Net exercise of stock warrants Net exercise of stock options Issuance of restricted stock
The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
From January 1, 2016 to June 30, 2016 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary's Prescription Pharmacy Transfer of common stock Issuance of common stock Net exercise of stock warrants Net exercise of stock options The Company effected a 1-for-1.94 reverse split of its common stock on September 16, 2016. The reverse split combined each 1.94 shares of the Company's issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion prices of its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional shares resulting from the reverse split were rounded down to the nearest whole share and in lieu of any fractional shares the Company will pay a cash amount to the holder of such fractional share equal to the fair market value of such fractional share as determined by the Board.
From January 1,2016 to March 31, 2016 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy Transfer of common stock Net exercise of stock warrants Net exercise of stock options
from January 1, 2015 to September 30, 2015 Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of St. Mary Prescription Pharmacy Issuance of common stock in connection with satisfaction of contingent consideration related to acquisition of Capstone Performance Systems, LLC Transfer of common stock Exercise of stock options